News for Healthier Living

Can GLP-1s Help People Stop Insulin?

A new study led by Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology and metabolism) at Yale School of Medicine, examined the impact of Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) therapy on rates of insulin discontinuation in people with type 2 diabetes compared with other oral medications typically prescribed to help manage blood sugar levels. The findings were published in Annals of Internal Medicine.

August 13, 2026


August 15 2026

August 14 2026

August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026